Cargando…

Signaling Overlap between the Golgi Stress Response and Cysteine Metabolism in Huntington’s Disease

Huntington’s disease (HD) is caused by expansion of polyglutamine repeats in the protein huntingtin, which affects the corpus striatum of the brain. The polyglutamine repeats in mutant huntingtin cause its aggregation and elicit toxicity by affecting several cellular processes, which include dysregu...

Descripción completa

Detalles Bibliográficos
Autor principal:	Paul, Bindu D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465517/ https://www.ncbi.nlm.nih.gov/pubmed/34573100 http://dx.doi.org/10.3390/antiox10091468

Ejemplares similares

Mutant Huntingtin Derails Cysteine Metabolism in Huntington’s Disease at Both Transcriptional and Post-Translational Levels
por: Paul, Bindu D., et al.
Publicado: (2022)

Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications
por: Paul, Bindu D., et al.
Publicado: (2019)

Overlap between age-at-onset and disease-progression determinants in Huntington disease
por: Aziz, N. Ahmad, et al.
Publicado: (2018)

DISC1 and Huntington's Disease – Overlapping Pathways of Vulnerability to Neurological Disorder?
por: Boxall, Ruth, et al.
Publicado: (2011)

Purine Nucleotides Metabolism and Signaling in Huntington’s Disease: Search for a Target for Novel Therapies
por: Tomczyk, Marta, et al.
Publicado: (2021)

The TGN38 glycoprotein contains two non-overlapping signals that mediate localization to the trans-Golgi network
Publicado: (1994)

Overlapping distribution of two glycosyltransferases in the Golgi apparatus of HeLa cells
Publicado: (1993)

Endoplasmic reticulum and Golgi stress in microcephaly
por: Passemard, Sandrine, et al.
Publicado: (2019)

Huntington’s Disease and Striatal Signaling
por: Roze, Emmanuel, et al.
Publicado: (2011)

Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington’s Disease
por: Maity, Shuvadeep, et al.
Publicado: (2022)

Irritability in Huntington’s Disease
por: Karagas, Nicholas E., et al.
Publicado: (2020)

Neurodegenerative processes in Huntington's disease
por: Bano, D, et al.
Publicado: (2011)

A Metabolic Study of Huntington’s Disease
por: Nambron, Rajasree, et al.
Publicado: (2016)

Golgi Complex: A Signaling Hub in Cancer
por: Spano, Daniela, et al.
Publicado: (2022)

Spermatozoan Metabolism as a Non-Traditional Model for the Study of Huntington’s Disease
por: Lawlor, Meghan, et al.
Publicado: (2022)

Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
por: Sönmez, Aynur, et al.
Publicado: (2021)

Cannabinoid signaling and risk in Huntington's disease
por: Humble, James, et al.
Publicado: (2022)

Dysregulated miRNA and mRNA Expression Affect Overlapping Pathways in a Huntington’s Disease Model
por: Zsindely, Nóra, et al.
Publicado: (2023)

Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington’s Disease
por: Simmons, Danielle A.
Publicado: (2017)

Golgi localization signals
por: Hurtley, Stella M.
Publicado: (1992)

Huntington Disease in Asia
por: Xu, Miao, et al.
Publicado: (2015)

The response of the Golgi complex to microtubule alterations: the roles of metabolic energy and membrane traffic in Golgi complex organization
Publicado: (1989)

SUMO-modifying Huntington’s disease
por: Soares, Ericks S., et al.
Publicado: (2022)

Golgi Structure and Function in Health, Stress, and Diseases
por: Li, Jie, et al.
Publicado: (2019)

DNA Methylation in Huntington’s Disease
por: Zsindely, Nóra, et al.
Publicado: (2021)

Olfactory Dysfunction in Huntington’s Disease
por: Patino, Jorge, et al.
Publicado: (2021)

Therapeutic Strategies in Huntington's Disease
por: Kanazawa, Ichiro
Publicado: (2006)

Neuropsychiatric Burden in Huntington’s Disease
por: Paoli, Ricardo Augusto, et al.
Publicado: (2017)

PET Imaging in Huntington’s Disease
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2015)

The Neurodevelopmental Hypothesis of Huntington’s Disease
por: van der Plas, Ellen, et al.
Publicado: (2020)

Therapeutic Advances for Huntington’s Disease
por: Kumar, Ashok, et al.
Publicado: (2020)

Golgi Dynamics: The Morphology of the Mammalian Golgi Apparatus in Health and Disease
por: Makhoul, Christian, et al.
Publicado: (2019)

Cysteine metabolic circuitries: druggable targets in cancer
por: Bonifácio, Vasco D. B., et al.
Publicado: (2020)

Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis
por: Bajaj, Rakhee, et al.
Publicado: (2022)

Golgi Stress Response: New Insights into the Pathogenesis and Therapeutic Targets of Human Diseases
por: Kim, Won Kyu, et al.
Publicado: (2023)

Downregulation of Genes Involved in Metabolism and Oxidative Stress in the Peripheral Leukocytes of Huntington's Disease Patients
por: Chang, Kuo-Hsuan, et al.
Publicado: (2012)

Targeting of proteins to the Golgi apparatus
por: Gleeson, Paul A.
Publicado: (1998)

Mechanisms of signal transduction by ethylene: overlapping and non-overlapping signalling roles in a receptor family
por: Shakeel, Samina N., et al.
Publicado: (2013)

Protein Misfolding and ER Stress in Huntington's Disease
por: Shacham, Talya, et al.
Publicado: (2019)

Golgi phosphoprotein 2 in physiology and in diseases
por: Kim, Ha-Jeong, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_pqh2n1c9ffqkm9tpvds9v6i95u